Predicted the P2RX7 rs3751143 polymorphism is associated with cancer risk: a meta-analysis and systematic review
- PMID: 33501930
- PMCID: PMC7859319
- DOI: 10.1042/BSR20193877
Predicted the P2RX7 rs3751143 polymorphism is associated with cancer risk: a meta-analysis and systematic review
Abstract
Background: Both meta-analyses and systematic reviews were used to assess the relationship between purinergic receptor P2X ligand-gated ion channel 7 (P2RX7) rs3751143 polymorphism and the risk of cancer.
Materials and methods: The data used in this research were collected from Google Scholar, Web of Science, CNKI, and Wan Fang Data databases. The final retrieval ended on 22 February 2019. The strength of correlation was assessed using odds ratios and 95% confidence intervals. Based on the heterogeneity test results, fixed-effect (Mantel-Haenszel) or random-effects (DerSimonian-Laird) models were selected to summarise the collective effects.
Results: Eight separate studies containing 1462 cancer cases and 3037 controls were enrolled. Overall, there was no significant association between P2RX7 rs3751143 polymorphism and the risk of cancer in the allelic, homozygous, heterozygous, dominant, or recessive models.
Conclusions: Our meta-analysis indicates that there is no significant association between P2RX7 rs3751143 polymorphism and the risk of cancer in the allelic, homozygous, heterozygous, dominant, and recessive models.
Keywords: P2RX7; cancer; meta analysis; polymorphism; rs3751143.
© 2021 The Author(s).
Conflict of interest statement
The authors declare that there are no competing interests associated with the manuscript.
Figures
Similar articles
-
Association between the rs3751143 polymorphism of P2RX7 gene and chronic lymphocytic leukemia: A meta-analysis.Purinergic Signal. 2020 Dec;16(4):479-484. doi: 10.1007/s11302-020-09737-8. Epub 2020 Oct 7. Purinergic Signal. 2020. PMID: 33026566 Free PMC article. Review.
-
Association between P2X7 Polymorphisms and Susceptibility to Tuberculosis: An Updated Meta-Analysis of Case-Control Studies.Medicina (Kaunas). 2019 Jun 21;55(6):298. doi: 10.3390/medicina55060298. Medicina (Kaunas). 2019. PMID: 31234470 Free PMC article.
-
Lack of association of P2RX7 gene rs2230912 polymorphism with mood disorders: a meta-analysis.PLoS One. 2014 Feb 12;9(2):e88575. doi: 10.1371/journal.pone.0088575. eCollection 2014. PLoS One. 2014. PMID: 24533115 Free PMC article.
-
Associations of P2X7 Polymorphisms with the Odds of Tuberculosis: A Meta-Analysis.Int Arch Allergy Immunol. 2019;179(1):74-80. doi: 10.1159/000494728. Epub 2019 Apr 10. Int Arch Allergy Immunol. 2019. PMID: 30970345
-
Association of P2X7 A1513C (rs3751143) gene polymorphism with risk of tuberculosis: evidence from a meta-analysis.Genet Test Mol Biomarkers. 2013 Sep;17(9):662-8. doi: 10.1089/gtmb.2013.0202. Epub 2013 Aug 15. Genet Test Mol Biomarkers. 2013. PMID: 23947898 Review.
Cited by
-
A loss-of-function polymorphism in ATG16L1 compromises therapeutic outcome in head and neck carcinoma patients.Oncoimmunology. 2022 Apr 17;11(1):2059878. doi: 10.1080/2162402X.2022.2059878. eCollection 2022. Oncoimmunology. 2022. PMID: 35481288 Free PMC article.
-
To inhibit or to boost the ATP/P2RX7 pathway to fight cancer-that is the question.Purinergic Signal. 2021 Dec;17(4):619-631. doi: 10.1007/s11302-021-09811-9. Epub 2021 Aug 4. Purinergic Signal. 2021. PMID: 34347213 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous